A frequently employed therapeutic approach for the supervision of hyperuricaemia in individuals suffering from gout involves the administration of allopurinol and febuxostat, which function as xanthine oxidase (XO) inhibitors [12,13]. The gene discussed is XDH; the disease is gout.